Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Immune responses to adenovirus and adeno-associated virus in humans

Chirmule, N, Propert, K J, Magosin, S A, Qian, Y, Qian, R, Wilson, J M · 1999 · Gene Therapy

Abstract

Vectors based on human adenovirus (Ad) and adeno-associated virus (AAV) are being evaluated for human gene therapy. The response of the host to the vector, in terms of antigen-specific immunity, will play a substantial role in clinical outcome. We have surveyed cohorts of normal subjects and cystic fibrosis patients for pre-existing immunity to these viruses, caused by naturally acquired infections. A number of humoral and cellular assays to adenovirus serotype 5 (Ad5) and adeno-associated virus serotype 2 (AAV2) were performed from serum and peripheral blood mononuclear cells. Virtually all subjects had Ig to Ad5 although only 55% of these antibodies neutralized virus (NAB). Approximately two of three patients demonstrated CD4+ T cells that proliferated to Ad antigens of which most were of the TH1 subset, based on cytokine secretion. A substantially different pattern of immune responses was observed to AAV2. Although virtually all patients had Ig to AAV2, most of these antibodies were not neutralizing (32% NAB) and only 5% of patients had peripheral blood lymphocytes that proliferated in response to AAV2 antigens. These studies demonstrate marked heterogeneity in pre-existing immunity to Ad5 and AAV2 in human populations. The impact of these findings on outcome following gene therapy will require further study.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.gt.3300994

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 1

  1. Wold SM, Tollefson AE, Hermiston TW . Strategies of immune modulation by adenoviruses In: G McFadden (ed) Viroceptors, Virokines and Related Immune Modulators Encoded by DAN Viruses RG Landes 1994 pp 147–185

Cited by

See all 692

Metadata

Authors
Chirmule, N., Propert, K. J., Magosin, S. A., Qian, Y., Qian, R., & Wilson, J. M.
Affiliations
  • University of Pennsylvania (US)
  • The Wistar Institute (US)
Venue
Gene Therapy
Published
1999-09-01
Volume
6
Issue
9
Pages
1574-1583
ISSN
  • 0969-7128 (ISSN-L)
  • 1476-5462
OpenAlex
W2079017842
Cited by
684
References
30
Citations by year
2026: 5 · 2025: 9 · 2024: 7 · 2023: 12 · 2022: 15 · 2021: 19 · 2020: 14 · 2019: 16 · 2018: 12 · 2017: 16 · 2016: 19 · 2015: 20 · 2014: 25 · 2013: 21 · 2012: 26
FWCI
15.14
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Gene Therapy (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK 47757, P50DK049136, P50 DK49136, P30DK047757)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
adenovirus, adeno-associated virus, pre-existing immunity, gene therapy vectors, adenovirus type 5, AAV2, neutralizing antibodies, humoral immunity, cell-mediated immunity, CD4+ T cells, Th1 response, cystic fibrosis, vector immunogenicity
MeSH terms
Dependovirus, Adenoviridae, Adult, Antibodies, Viral, B-Lymphocytes, Cells, Cultured, Cystic Fibrosis, Female, Genetic Vectors, Humans, Immunoglobulin G, Lymphocyte Activation, Male, Middle Aged, T-Lymphocytes, Blotting, Western, Chi-Square Distribution, Case-Control Studies, Cytokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune responses to adenovirus and adeno-associated virus in humans. https://app.cochat.ai/papers/10.1038/sj.gt.3300994
The paper
Chirmule, N., Propert, K. J., Magosin, S. A., Qian, Y., Qian, R., & Wilson, J. M. (1999). Immune responses to adenovirus and adeno-associated virus in humans. Gene Therapy. https://doi.org/10.1038/sj.gt.3300994

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.